213 related articles for article (PubMed ID: 20038798)
1. The Rho/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells.
Sauzeau V; Sevilla MA; Montero MJ; Bustelo XR
J Clin Invest; 2010 Jan; 120(1):315-30. PubMed ID: 20038798
[TBL] [Abstract][Full Text] [Related]
2. Genetic dissection of the vav2-rac1 signaling axis in vascular smooth muscle cells.
Fabbiano S; Menacho-Márquez M; Sevilla MA; Albarrán-Juárez J; Zheng Y; Offermanns S; Montero MJ; Bustelo XR
Mol Cell Biol; 2014 Dec; 34(24):4404-19. PubMed ID: 25288640
[TBL] [Abstract][Full Text] [Related]
3. Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.
Higashi Y
Int J Urol; 2017 Jun; 24(6):412-424. PubMed ID: 28332240
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells: role of nitric oxide and cyclic guanosine monophosphate signaling pathways.
Begum N; Sandu OA; Duddy N
Diabetes; 2002 Jul; 51(7):2256-63. PubMed ID: 12086958
[TBL] [Abstract][Full Text] [Related]
5. Smooth muscle specific Rac1 deficiency induces hypertension by preventing p116RIP3-dependent RhoA inhibition.
André G; Sandoval JE; Retailleau K; Loufrani L; Toumaniantz G; Offermanns S; Rolli-Derkinderen M; Loirand G; Sauzeau V
J Am Heart Assoc; 2014 Jun; 3(3):e000852. PubMed ID: 24938713
[TBL] [Abstract][Full Text] [Related]
6. RhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor alpha and stimulation of vascular smooth muscle cell migration.
Rolli-Derkinderen M; Toumaniantz G; Pacaud P; Loirand G
Mol Cell Biol; 2010 Oct; 30(20):4786-96. PubMed ID: 20696841
[TBL] [Abstract][Full Text] [Related]
7. Are the mechanisms for NO-dependent vascular remodeling different from vasorelaxation in vivo?
Schleicher M; Sessa WC
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1207-8. PubMed ID: 18565841
[No Abstract] [Full Text] [Related]
8. Smooth muscle-specific deletion of nitric oxide-sensitive guanylyl cyclase is sufficient to induce hypertension in mice.
Groneberg D; König P; Wirth A; Offermanns S; Koesling D; Friebe A
Circulation; 2010 Jan; 121(3):401-9. PubMed ID: 20065162
[TBL] [Abstract][Full Text] [Related]
9. Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding.
Rizzo NO; Maloney E; Pham M; Luttrell I; Wessells H; Tateya S; Daum G; Handa P; Schwartz MW; Kim F
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):758-65. PubMed ID: 20093624
[TBL] [Abstract][Full Text] [Related]
10. HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta.
Wang SE; Shin I; Wu FY; Friedman DB; Arteaga CL
Cancer Res; 2006 Oct; 66(19):9591-600. PubMed ID: 17018616
[TBL] [Abstract][Full Text] [Related]
11. Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway.
Chau VQ; Salloum FN; Hoke NN; Abbate A; Kukreja RC
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2272-9. PubMed ID: 21398594
[TBL] [Abstract][Full Text] [Related]
12. EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway.
Deroanne C; Vouret-Craviari V; Wang B; Pouysségur J
J Cell Sci; 2003 Apr; 116(Pt 7):1367-76. PubMed ID: 12615978
[TBL] [Abstract][Full Text] [Related]
13. Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis.
Lukowski R; Weinmeister P; Bernhard D; Feil S; Gotthardt M; Herz J; Massberg S; Zernecke A; Weber C; Hofmann F; Feil R
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1244-50. PubMed ID: 18420996
[TBL] [Abstract][Full Text] [Related]
14. The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice.
Williams J; Bogwu J; Oyekan A
J Hypertens; 2006 Jul; 24(7):1429-36. PubMed ID: 16794494
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice.
Priviero FB; Jin LM; Ying Z; Teixeira CE; Webb RC
J Pharmacol Exp Ther; 2010 Apr; 333(1):184-92. PubMed ID: 20093396
[TBL] [Abstract][Full Text] [Related]
16. Vav2 is an activator of Cdc42, Rac1, and RhoA.
Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
[TBL] [Abstract][Full Text] [Related]
17. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.
Morelli A; Filippi S; Sandner P; Fibbi B; Chavalmane AK; Silvestrini E; Sarchielli E; Vignozzi L; Gacci M; Carini M; Vannelli GB; Maggi M
J Sex Med; 2009 Jun; 6(6):1594-1608. PubMed ID: 19473460
[TBL] [Abstract][Full Text] [Related]
18. Collagen phagocytosis is regulated by the guanine nucleotide exchange factor Vav2.
Arora PD; Marignani PA; McCulloch CA
Am J Physiol Cell Physiol; 2008 Jul; 295(1):C130-7. PubMed ID: 18434624
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.
Das A; Xi L; Kukreja RC
J Biol Chem; 2005 Apr; 280(13):12944-55. PubMed ID: 15668244
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cGMP phosphodiesterase 5 suppresses serotonin signalling in pulmonary artery smooth muscles cells.
Li M; Sun X; Li Z; Liu Y
Pharmacol Res; 2009 May; 59(5):312-8. PubMed ID: 19416631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
